On September 6, 2022 thenex (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, reported that management will present at the H.C. Wainwright 24th Annual Global Investment Conference, taking place September 12-14, 2022, in New York, NY and virtually (Press release, Athenex, SEP 6, 2022, View Source [SID1234619038]). Company management will also be available for one-on-one investor meetings during the event. Please find additional details about the presentation below.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A replay of the presentation will be available in the "Events and Presentations" section of the Athenex website for the following 90 days. Please contact your representative at H.C. Wainwright to schedule a virtual one-on-one meeting with Athenex during the conference. For information about the H.C. Wainwright Global Investment Conference, please refer to the event’s website.